Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02066181
Title Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

sarcoma

Therapies

Sorafenib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.